2 ms·
There were, I think, fair reasons to do this. A patent-free "people's vaccine" may well have reached fewer people because there's got to be money in scaling up
by argsnd 1y ago
There were, I think, fair reasons to do this. A patent-free "people's vaccine" may well have reached fewer people because there's got to be money in scaling up the production of something like this.
- wormlord 1y agoIt also conveniently benefits him greatly.
- PieTime 1y agoHe’s also buying up a lot of farm land in US…
- ChicagoDave 1y agoHow? Guy doesn’t need anything. He’s never played the greedy billionaire part. Vaccine IP is also a moving target. You need experts to work at it non-stop. Covid-19 mutates every three months.